Jennifer Lew
CIK 1465994 · EVP & CHIEF FINANCIAL OFFICER · last filed 2026-06-15
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
ADRO price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
1400 SIERRA POINT PARKWAY, BLDG C, 200
BRISBANE, CA 94005
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BOLD | Director | — | $2.42 | — | $0 | 3 | 2026-06-15 |
| ANNX | EVP & CHIEF FINANCIAL OFFICER | 170,700 | $3.79 | $646.1K | -$401.8K | 20 | 2026-03-04 |
| CHINOOK THERAPEUTICS, INC. (ADRO) Delisted | Chief Financial Officer | 147,299 | — | — | -$1.56M | 27 | 2019-05-03 |
| DYNAVAX TECHNOLOGIES CORP (DVAX) Delisted | VP, Finance & PAO | 2,108 | $15.50 | $32.7K | -$84.9K | 6 | 2013-02-07 |
Recent Filings · Page 2 of 7
65 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-02-20 | ANNX | Sell (S) | −6,912 | -$20.2K | EDGAR |
| 2025-02-18 | ANNX | Notice (144) | −8,338 | -$24.3K | EDGAR |
| 2025-02-18 | ANNX | Sell (S) | −1,786 | -$5.3K | EDGAR |
| 2025-02-13 | ANNX | Notice (144) | −1,786 | -$5.3K | EDGAR |
| 2024-07-17 | ANNX | Sell (S) | −1,104 | -$6.7K | EDGAR |
| 2024-07-15 | ANNX | Notice (144) | −1,104 | -$6.7K | EDGAR |
| 2024-03-29 | BOLD | Grant (A) | — | $0 | EDGAR |
| 2024-02-21 | ANNX | Mixed | +36,407 | -$14.3K | EDGAR |
| 2024-02-20 | ANNX | Notice (144) | −2,593 | -$14.3K | EDGAR |
| 2024-02-14 | ANNX | Sell (S) | −1,809 | -$10.0K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.